Patent · US Active

Compositions and methods for delivery of AAV

US12305189B2 · kind B2 · utility

0Cited by
188References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 20, 2022
Grant dateMay 20, 2025
Priority date
Expiry dateJan 21, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for the preparation, manufacture, formulation and therapeutic use of adeno-associated virus (AAV) particles for the prevention and/or treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.